Spruce Biosciences, Inc. (SPRB) PT Lowered to $150 at Citizens After Q1 Results, Model Update
Citizens analyst Jonathan Wolleben lowered the price target on Spruce Biosciences, Inc. (NASDAQ: SPRB) to $150.00 (from $170.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)